Rhinitis and its impact on work

Current Opinion in Allergy and Clinical Immunology

Volumn 8, Issue 2, 2008, Pages 145-149

  Vandenplas, Olivier ^a,c   D'Alpaos, Vinciane ^a   Van Brussel, Philippe ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Mensura Service Externe de Prévention et Protection SEPP   (Belgium)

^c UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

Economics; Rhinitis; Work productivity

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT;

ABSENTEEISM; ALLERGIC RHINITIS; COST OF ILLNESS; DISEASE SEVERITY; EXPOSURE; HUMAN; JOB PERFORMANCE; MAGNITUDE ESTIMATION METHOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; WORK DISABILITY;

ABSENTEEISM; ALLERGENS; ENVIRONMENTAL EXPOSURE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; RHINITIS; SEVERITY OF ILLNESS INDEX; TASK PERFORMANCE AND ANALYSIS; WORK CAPACITY EVALUATION;

EID: 43249084945     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3282f63d92     Document Type: Review

References (31)

1. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994; 94 (2 Pt 1):182-188.
2. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007; 28:3-9.
3. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22:225-244.
4. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4:353-365.
5. Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999; 41:948-953.
6. Burton WN, Conti DJ, Chen CY, et al. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med 2001; 43:64-71.
7. Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J 2003; 22:689-697.
8. Vandenplas O, Henneberger PK. Socioeconomic outcomes in work-exacerbated asthma. Curr Opin Allergy Clin Immunol 2007; 7:236-241.
9. Yelin E, Katz P, Balmes J, et al. Work life of persons with asthma, rhinitis, and COPD: a study using a national, population-based sample. J Occup Med Toxicol 2006; 1:2.
10. Malone DC, Lawson KA, Smith DH, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997; 99 (1 Pt 1):22-27.
11. McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy 1994; 73:35-39.
12. Ward MM, Javitz HS, Smith WM, Whan MA. Lost income and work limitations in persons with chronic respiratory disorders. J Clin Epidemiol 2002; 55:260-268.
13. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000; 6:373-378.
14. Schramm B, Ehlken B, Smala A, et al. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003; 21:116-122.
15. Hanrahan LP, Paramore LC. Aeroallergens, allergic rhinitis, and sedating antihistamines: risk factors for traumatic occupational injury and economic impact. Am J Ind Med 2003; 44:438-446.
16. Goetzel RZ, Long SR, Ozminkowski RJ, et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 2004; 46:398-412.
17. Demoly P, Allaert FA, Lecasble M. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002; 57:546-554.
18. Blanc PD, Trupin L, Eisner M, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001; 54:610-618.
19. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006; 22:1203-1210. This survey compared the impact of rhinitis on work productivity with that resulting from other health condition. The survey was, however, based on convenience sample, which might have bias the findings.
20. Szeinbach SL, Seoane-Vazquez EC, Beyer A, Williams PB. The impact of allergic rhinitis on work productivity. Prim Care Respir J 2007; 16:98-105. This study provides interesting information on the factors that determine the impact of allergic rhinitis on work productivity in a large sample of a managed care organization members.
21. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (5 Suppl):S147-S334.
22. Bousquet J, Neukirch F, Bousquet PJ, et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006; 117:158-162. This survey evaluated the impact of the severity and duration of rhinitis symptoms on quality of life and work productivity in a large population of patients seen by general practitioners.
23. Kessler RC, Almeida DM, Berglund P, Stang P. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol 2001; 87:289-295.
24. Gautrin D, Desrosiers M, Castano R. Occupational rhinitis. Curr Opin Allergy Clin Immunol 2006; 6:77-84.
25. Groenewoud GC, de Groot H, van Wijk RG. Impact of occupational and inhalant allergy on rhinitis-specific quality of life in employees of bell pepper greenhouses in the Netherlands. Ann Allergy Asthma Immunol 2006; 96:92-97. This is the first attempt at characterizing the impact of exposure to occupational allergens on quality of life in workers suffering from rhinitis.
26. Sussman GL, Mason J, Compton D, et al. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J Allergy Clin Immunol 1999; 104:100-106.
27. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1999; 83:311-317.
28. Tanner A, Reilly M, Meltzer EO, et al. Effect of fexofenadine HCI on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Manag Care 1999; 5:S235-S246.
29. Murray JJ, Nathan RA, Bronsky EA, et al. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 2002; 23:391-398.
30. Okubo K, Gotoh M, Shimada K, et al. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005; 136:148-154.
31. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004; 114:838-844.